Top compounds associated with response to GPI


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.2
mRNA JW-55 CTRPv2 pan-cancer AAC -0.088 0.2
mRNA pac-1 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA Bax channel blocker CTRPv2 pan-cancer AAC -0.043 0.3
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA SB-431542 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA HC-067047 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.056 0.3
Download CSV